PHOENIX, AZ & SAN FRANCISCO, CA (March 3, 2021) – Carrick Capital Partners, a leading growth-oriented investment firm managing over $1 billion in assets, has announced a significant investment in Renalogic, an industry frontrunner in dialysis risk management and cost containment solutions. This strategic move underscores Carrick Capital Partners’ focus on high-growth, software-enabled businesses and their expanding portfolio within the healthcare sector.
Renalogic has established itself as a pivotal player in the healthcare landscape, experiencing substantial growth as employers grapple with the escalating costs associated with chronic kidney disease (CKD). The company adopts a comprehensive strategy to mitigate CKD-related risks, providing effective interventions for high-risk populations, patient education programs, advocacy, and innovative dialysis cost management strategies. A key differentiator for Renalogic is its recently introduced CareINSIGHTS.ai platform. This cutting-edge predictive modeling and artificial intelligence tool enhances Renalogic’s personalized, high-touch intervention approach, enabling proactive identification of previously undetected CKD risks. This proactive capability represents a significant advancement in an industry struggling to control substantial claim expenses, positioning Renalogic as a solution that delivers improved patient outcomes and considerable cost savings compared to conventional multiple-of-Medicare reference-based pricing models, while minimizing risk.
This investment by Carrick Capital Partners highlights a growing trend in the self-funded employer market, where innovative health solution providers are increasingly sought after to address rising healthcare expenditures. Carrick Capital Partners recognizes that self-funded employers, particularly in the mid-market segment, are actively seeking novel approaches to cost containment and risk management to counter increasing Preferred Provider Organization (PPO) costs. Carrick Capital Partners’ investment in Renalogic and the CKD cost containment sector builds upon their prior successful healthcare investments, including Accolade, InstaMed, and Discovery Healthcare Partners, demonstrating their continued commitment to the healthcare technology space.
“Renalogic has proven its effectiveness in maximizing savings for employers while ensuring a positive experience for employees in managing CKD, a disease area that is both critically important and challenging for healthcare cost management,” stated Chris Wenner, Managing Director at Carrick Capital Partners.
Wenner further added, “We are excited to collaborate with the talented team at Renalogic to strengthen their leading market position in dialysis by expanding their service offerings. This expansion will further assist self-funded employers and stop-loss carriers in effectively managing catastrophic risk associated with CKD and dialysis costs.”
Renalogic CEO Lisa Moody commented, “Renalogic has achieved remarkable growth over the past three years by successfully assisting health plans and their members in reducing the risks associated with Chronic Kidney Disease. Carrick Capital Partners’ deep expertise in the healthcare sector, combined with their specific focus on software and technology-enabled businesses, makes them an ideal partner to help us expand our mission-driven business. This partnership will enable us to scale our operations to support our expanding client base and further innovate within the dialysis risk management space.”
As part of this investment transaction, Managing Directors Steve Unterberger and Chris Wenner from Carrick Capital Partners will join Lisa Moody on the Renalogic Board of Directors. Covington, LLC acted as the exclusive financial advisor to Renalogic in this transaction.
About Carrick Capital Partners
Carrick Capital Partners, headquartered in San Francisco and Newport Beach, is a growth-focused investment firm that employs its proprietary Approach to Building Value (ABV) methodology to operationally scale rapidly growing, technology-driven businesses. Carrick Capital Partners distinguishes itself through its concentrated investment strategy and commitment to providing substantial post-investment resources. Leveraging decades of collective experience, Carrick Capital Partners is dedicated to scaling exceptional companies that generate strong returns for investors, stimulate economic advancement, and create positive transformations within their respective industries. By working in close partnership with CEOs and entrepreneurs, Carrick Capital Partners fulfills a critical need for both investment capital and strategic growth expertise in the market. For more detailed information, please visit http://www.carrickcapitalpartners.com/.
